Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Morel

Showing results (11-20 of 197) with videos related to

Pageof 20
Sort By:
Optics Letters|September 21, 2011
Pulsed erbium fiber laser with an acetylene-filled photonic crystal fiber for saturable absorptionPatrick Thomas Marty, Jacques Morel, Thomas Feurer
AJR. American Journal of Roentgenology|May 23, 2006
On the AJR viewbox. Pseudotumoral colonic tuberculosis complicating rheumatoid arthritis treated with a tumor necrosis factor antagonistAlvian Lesnik, Julie Bolivar, Jacques Morel, et al.
Therapie|January 21, 2019
How to improve vaccine acceptability (evaluation, pharmacovigilance, communication, public health, mandatory vaccination, fears and beliefs)Alain Dutilleul, Jacques Morel, Clémentine Schilte, et al.
Joint Bone Spine|December 4, 2019
Practical management of patients on Janus kinase inhibitor (JAKi) therapy - the CRI fact sheetsChristophe Richez, Jacques Morel, Jean Sibilia, et al.
Clinical and Experimental Rheumatology|January 28, 2021
Change in MRI in patients with spondyloarthritis treated with anti-TNF agents: systematic review of the literature and meta-analysisGisèle Khoury, Bernard Combe, Jacques Morel, et al.
Joint Bone Spine|August 13, 2013
Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysisHelene Che, Cedric Lukas, Jacques Morel, et al.
Cytokine|May 9, 2013
The two directions of TNF-related apoptosis-inducing ligand in rheumatoid arthritisRachel Audo, Bernard Combe, Michael Hahne, et al.
The Journal of Biological Chemistry|February 3, 2005
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/AktJacques Morel, Rachel Audo, Michael Hahne, et al.
The Journal of Rheumatology|May 5, 2010
Scurvy as the presenting illness of Whipple's disease exacerbated by treatment with etanercept in a patient with ankylosing spondylitisIhsane Hmamouchi, Valérie Costes, Bernard Combe, et al.
Rheumatology (Oxford, England)|July 2, 2010
Efficacy of rituximab in a patient with lupus nephritis despite low levels of CD19Ludovic Bacconnier, Bernard Combe, Bernard Canaud, et al.
Pageof 20

Showing results (11-20 of 197) with videos related to

Sort By:
Pageof 20
Optics Letters|September 21, 2011
Pulsed erbium fiber laser with an acetylene-filled photonic crystal fiber for saturable absorptionPatrick Thomas Marty, Jacques Morel, Thomas Feurer
AJR. American Journal of Roentgenology|May 23, 2006
On the AJR viewbox. Pseudotumoral colonic tuberculosis complicating rheumatoid arthritis treated with a tumor necrosis factor antagonistAlvian Lesnik, Julie Bolivar, Jacques Morel, et al.
Therapie|January 21, 2019
How to improve vaccine acceptability (evaluation, pharmacovigilance, communication, public health, mandatory vaccination, fears and beliefs)Alain Dutilleul, Jacques Morel, Clémentine Schilte, et al.
Joint Bone Spine|December 4, 2019
Practical management of patients on Janus kinase inhibitor (JAKi) therapy - the CRI fact sheetsChristophe Richez, Jacques Morel, Jean Sibilia, et al.
Clinical and Experimental Rheumatology|January 28, 2021
Change in MRI in patients with spondyloarthritis treated with anti-TNF agents: systematic review of the literature and meta-analysisGisèle Khoury, Bernard Combe, Jacques Morel, et al.
Joint Bone Spine|August 13, 2013
Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysisHelene Che, Cedric Lukas, Jacques Morel, et al.
Cytokine|May 9, 2013
The two directions of TNF-related apoptosis-inducing ligand in rheumatoid arthritisRachel Audo, Bernard Combe, Michael Hahne, et al.
The Journal of Biological Chemistry|February 3, 2005
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/AktJacques Morel, Rachel Audo, Michael Hahne, et al.
The Journal of Rheumatology|May 5, 2010
Scurvy as the presenting illness of Whipple's disease exacerbated by treatment with etanercept in a patient with ankylosing spondylitisIhsane Hmamouchi, Valérie Costes, Bernard Combe, et al.
Rheumatology (Oxford, England)|July 2, 2010
Efficacy of rituximab in a patient with lupus nephritis despite low levels of CD19Ludovic Bacconnier, Bernard Combe, Bernard Canaud, et al.
Pageof 20